LifeSci Venture Partners is a venture capital firm in New York that focuses on biotech and health sectors. Founded 2017 in New York, United States by Paul Yook, it invests in early stage ventures. Its portfolio companies include Cala Health, Biolinq, Attune Pharmaceuticals, Akero Therapeutics, Orasis Pharmaceuticals, and Allakos. As of March 2020, LifeSci Venture Partners has made seven investments. Their most recent investment was on May 21, 2019, when Cala Health raised $50M. LifeSci Venture Partners has had two exits, the most notable of which include Allakos and Akero Therapeutics.
Timeline
Funded Companies
Akero Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state.
Biolinq, Inc. is a San Diego-based company founded by Joshua Windmiller.
People
Julie Mauser
Executive
Paul Yook
Founder
Ryan Cinalli Ph.D
Executive
Further reading
Documentaries, videos and podcasts
Companies
Akero Therapeutics
Attune Pharmaceuticals
Biolinq
Cala Health
Orasis Pharmaceuticals